{"denoms":[{"counts":[{"groupId":"BG000","value":"462"},{"groupId":"BG001","value":"450"},{"groupId":"BG002","value":"912"}],"units":"Participants"}],"groups":[{"description":"experimental group (arm B) M1 scheme\n\nM1 scheme: short course 5 x 5 Gy radiation scheme is followed by six cycles of combination chemotherapy (capecitabine and oxaliplatin (CAPOX)) and surgery. FOLFOX4 may be given as alternative for CAPOX","id":"BG000","title":"B: 5x5Gy -> CAPOX -> Surgery"},{"description":"control group (arm A) standard long course chemoradiotherapy\n\nstandard long course chemoradiotherapy: long course chemoradiotherapy followed by surgery. Optional adjuvant chemotherapy (CAPOX or FOLFOX) is allowed in the control group.","id":"BG001","title":"A: 5 Weeks Chemoradiation -> Surgery"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"31","upperLimit":"83","value":"62"},{"groupId":"BG001","lowerLimit":"23","upperLimit":"84","value":"62"},{"groupId":"BG002","lowerLimit":"23","upperLimit":"84","value":"62"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"462"},{"groupId":"BG001","value":"450"},{"groupId":"BG002","value":"912"}],"units":"Participants"}]}],"dispersionType":"FULL_RANGE","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"162"},{"groupId":"BG001","value":"138"},{"groupId":"BG002","value":"300"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"300"},{"groupId":"BG001","value":"312"},{"groupId":"BG002","value":"612"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"462"},{"groupId":"BG001","value":"450"},{"groupId":"BG002","value":"912"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG002","value":"0"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Race and Ethnicity were not collected from any participant.","title":"Race and Ethnicity Not Collected","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"180"},{"groupId":"BG001","value":"180"},{"groupId":"BG002","value":"360"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"462"},{"groupId":"BG001","value":"450"},{"groupId":"BG002","value":"912"}],"units":"Participants"}],"title":"Netherlands"},{"categories":[{"measurements":[{"groupId":"BG000","value":"168"},{"groupId":"BG001","value":"160"},{"groupId":"BG002","value":"328"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"462"},{"groupId":"BG001","value":"450"},{"groupId":"BG002","value":"912"}],"units":"Participants"}],"title":"Sweden"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"20"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"462"},{"groupId":"BG001","value":"450"},{"groupId":"BG002","value":"912"}],"units":"Participants"}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"23"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"462"},{"groupId":"BG001","value":"450"},{"groupId":"BG002","value":"912"}],"units":"Participants"}],"title":"Norway"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"28"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"462"},{"groupId":"BG001","value":"450"},{"groupId":"BG002","value":"912"}],"units":"Participants"}],"title":"Denmark"},{"categories":[{"measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"35"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"462"},{"groupId":"BG001","value":"450"},{"groupId":"BG002","value":"912"}],"units":"Participants"}],"title":"Slovenia"},{"categories":[{"measurements":[{"groupId":"BG000","value":"58"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"118"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"462"},{"groupId":"BG001","value":"450"},{"groupId":"BG002","value":"912"}],"units":"Participants"}],"title":"Spain"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}],"populationDescription":"Eligible patients included in the overall study 468/920 were assigned to treatment B. 462/468 were eligible, 6/468 were ineligible 452/920 were assigned to treatment A. 450/452 were eligible, 9/452 were ineligible"}